31st August 2022, Stevenage, UK — Laverock Therapeutics Ltd was founded to develop a unique gene silencing platform for the creation of programmable, allogeneic cell therapies. Having recently completed a seed funding round, the Company has opened dedicated labs in the Stevenage Bioscience Catalyst, employing six new team members on top of an experienced senior management team. [Read more…]
Steakholder Foods Initiates Cultured Pork Development Using a Porcine Cell Line with Significantly Greater Lifespan and Scalability
The new induced pluripotent porcine stem cell line (iPS) enables the company to continue diversifying its species portfolio and accelerate its market readiness for cultured pork production
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
New partnership delivers clinically proven products and manufacturing processes for advanced therapies
SEATTLE, Aug. 16, 2022 — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services.
10 International Scientists Nominated For The $100,000 Stem Cell SpaceShot Grant
Bordeaux, France / August 30th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the nomination of 10 international scientists for the Stem Cell SpaceShot grant. Each nominee was anonymously selected based on a 1-page research project description. In early October, the 10 nominees will be interviewed by an international jury of experts in stem cell biology, gene editing and biophysics, which will determine the winner of the $100,000 Stem Cell SpaceShot Grant. [Read more…]
Ageless Biotech Signs Agreement with Simon Med Imaging of Scottsdale, AZ, One of the Nation’s Largest Siemens 3 Tesla MRI 3D Scan Outpatient Providers, to Advance Its FDA Approved IND Trial
SHERIDAN, Wyo., Aug. 23, 2022 — Ageless Biotech (ABT), Inc., a biotech company created to bring Stem Cell-based Therapeutics to market, is excited to have Simon Med Imaging, one of the major players within the healthcare and biotech research fields, helping to advance its U.S. Food and Drug Administration (FDA) Investigational New Drug Application (IND) for the treatment of Osteoarthritis of the Knee. [Read more…]
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 97
- Next Page »